First confirmation by genotyping of transplacental choriocarcinoma transmission.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 23850527.
- Also identified by DOI 10.1016/j.ajog.2013.07.002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A mother developed multimetastatic gestational choriocarcinoma 13 months after delivery, and her infant died aged 11 months from the same tumor. The transplacental choriocarcinoma transmission was confirmed by genotyping. Henceforth, we recommend a 2-year maternal human chorionic gonadotropin follow-up after neonatal choriocarcinoma and extensive imaging if the human chorionic gonadotropin rises.
Medical subject headings
- Choriocarcinoma
- Chorionic Gonadotropin
- Liver Neoplasms
- Maternal-Fetal Exchange
- Pregnancy Complications, Neoplastic
- Uterine Neoplasms